Skip to main content

Advertisement

Log in

Role of Placenta Accreta Index for Diagnosis of Placenta Accreta Spectrum in High-Risk Patients

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Background

Antenatal diagnosis of placenta accreta spectrum (PAS) can ensure multidisciplinary management at center of excellence which can reduce maternal and fetal complications. This can be established by a scoring system which provides a standardized criterion for the diagnosis and management. The objective of our study was to assess the placenta accreta index (PAI) and its individual parameters for diagnosis of PAS in high-risk patients.

Methods

A prospective study was conducted on 71 pregnant women with placenta previa and previous cesarean section. After informed consent, history was taken and ultrasonography was used to calculate the PAI for each patient. Definitive diagnosis was made clinically during cesarean section or by histopathology for those requiring hysterectomy. The data were evaluated using the latest version of Statistical Package for the Social Sciences software.

Results

All ultrasound parameters of placenta accreta index were statistically significant for predicting PAS (p value < 0.001). ROC curve with AUC of 0.87 95% CI of 0.77–0.94 showed that a score of 4.75 was the best cutoff value to diagnose PAS. Out of the 30 patients found to have placental invasion, 22 had a PAI score of more than 4.75. The score was found to have a sensitivity of 73.3%, specificity 95.1%, positive predictive value 91.7%, negative predictive value 83% and diagnostic accuracy 85.9%.

Conclusions

Women with placenta previa and history of previous CS should undergo screening by PAI, and a cutoff value of ≥ 4.75 should be viewed with high index of suspicion for the presence of PAS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jauniaux E, Collins S, Burton GJ. The placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218:75–87.

    Article  Google Scholar 

  2. Mittal P, Suri J, Pruthi N, et al. Comparison of placenta accreta spectrum disorders diagnosed in intrapartum and antepartum period—a three year experience in a tertiary referral unit of India. Eur J Obstet Gynecol Reprod Biol. 2019;236:41–5.

    Article  Google Scholar 

  3. Fan D, Li S, Wu S, et al. Prevalence of abnormally invasive placenta among deliveries in mainland China: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2017;96:6636.

    Article  Google Scholar 

  4. Shamshirsaz AA, Fox KA, Salmanian B, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015;212:218.

    Article  Google Scholar 

  5. Silver RM, Fox KA, Barton JR, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015;212:561–8.

    Article  Google Scholar 

  6. Colmorn LB, Krebs L, Jakobsson M, et al. Mode of first delivery and severe maternal complications in the subsequent pregnancy. Acta Obstet Gynecol Scand. 2017;96:1053–62.

    Article  Google Scholar 

  7. Erfani H, Fox KA, Clark SL, et al. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team. Am J Obstet Gynecol. 2019;221:337.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Thurn L, Lindqvist PG, Jakobsson M, et al. Abnormally invasive placenta—prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. Br J Obstet Gynaecol. 2016;123:1348–55.

    Article  CAS  Google Scholar 

  9. Sentilhes L, Merlot B, Madar H, et al. Postpartum haemorrhage: prevention and treatment. Expert Rev Hematol. 2016;9:1043–61.

    Article  CAS  Google Scholar 

  10. D’Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2013;42:509–17.

    Article  Google Scholar 

  11. Jauniaux E, Collins SL, Jurkovic D, et al. Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol. 2016;215:712–21.

    Article  Google Scholar 

  12. Collins SL, Ashcroft A, Braun T, et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol. 2016;47:271–5.

    Article  CAS  Google Scholar 

  13. Pilloni E, Alemanno MG, Gaglioti P, et al. Accuracy of ultrasound in antenatal diagnosis of placental attachment disorders. Ultrasound in Obstet Gynecol. 2016;47:302–7.

    Article  CAS  Google Scholar 

  14. Tanimura K. PPAP scoring system predicts adherent placenta in women with placenta previa. Placenta. 2017;59:172.

    Article  Google Scholar 

  15. D’Antonio F, Iacovella C, Palacios-Jaraquemada J, et al. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2014;44:8–16.

    Article  Google Scholar 

  16. Meng X, Xie L, Song W. Comparing the diagnostic value of ultrasound and magnetic resonance imaging for placenta accreta: a systematic review and meta-analysis. Ultrasound Med Biol. 2013;39:1958–65.

    Article  Google Scholar 

  17. Rac MW, Dashe JS, Wells CE, et al. Ultrasound predictors of placental invasion: the Placenta Accreta Index. Am J Obstet Gynecol. 2015;212:343.

    PubMed  Google Scholar 

  18. Jauniaux E, Bhide A, Kennedy A, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140:274–80.

    Article  Google Scholar 

  19. American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine. Placenta accreta spectrum: obstetric care consensus #7. Am J Obstet Gynecol. 2018; 219:2–16.

  20. Finberg HJ, Williams JW. Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med. 1992;11:333–43.

    Article  CAS  Google Scholar 

  21. Samosir SM, Irianti S, Tjahyadi D. Diagnostic test of placenta accreta index score (PAIS) as supporting prenatal diagnosis and outcomes of maternal neonatal in abnormally invasive placenta management at general hospital of Hasan Sadikin Bandung. Int J Reprod Contracept Obstet Gynecol. 2017;6:3765–9.

    Article  Google Scholar 

  22. El Lakwa H, Sanad Z, Hamza HA, et al. Evaluation of placenta accreta index to predict placental invasion in patients with placenta previa. Menoufia Med J. 2019;32:1359.

    Article  Google Scholar 

  23. De Mucio B, Serruya S, Alemán A, et al. A systematic review and meta-analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta. Int J Gynaecol Obstet. 2019;147:281–91.

    Article  Google Scholar 

  24. Abu Hashim H, Shalaby EM, Hussien MH, et al. Diagnostic accuracy of the placenta accreta index for placenta accreta spectrum: a prospective study. Int J Gynaecol Obstet. 2021;6:66.

    Google Scholar 

  25. Agarwal S, Agarwal A, Chandak S. Role of placenta accreta index in prediction of morbidly adherent placenta: a reliability study. Ultrasound. 2020;6:66.

    Google Scholar 

  26. Happe SK, Yule CS, Spong CY, et al. Predicting placenta accreta spectrum: validation of the placenta accreta index. J Ultrasound Med. 2020;6:66.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jyotsna Suri.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in the study were in accordance with the ethical standards of the institution and done after ethical clearance from the institution.

Informed Consent

Informed consent was obtained from all individual participants.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Dr. Sugandha Bansal (MBBS) is a Resident, Department of Obstetrics and Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India; Dr. Jyotsna Suri (MD) is a Professor, Department of Obstetrics and Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India; Dr. S. K. Bajaj (MD) is a Professor, Department of Radio-diagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India; Dr. Charanjeet Ahluwalia (MD) is a Professor, Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India; Dr. Divya Pandey (MD) is a Associate Professor, Department of Obstetrics and Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India; Dr. Pratima Mittal (MD) is a Professor, Department of Obstetrics and Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bansal, S., Suri, J., Bajaj, S.K. et al. Role of Placenta Accreta Index for Diagnosis of Placenta Accreta Spectrum in High-Risk Patients. J Obstet Gynecol India 72 (Suppl 1), 55–60 (2022). https://doi.org/10.1007/s13224-021-01541-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-021-01541-7

Keywords

Navigation